pirfenidone has been researched along with Nausea in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, L; Wang, Y; Zang, C; Zheng, Y | 1 |
| Chang, J; Choi, JS; Chung, KS; Jung, JY; Kang, YA; Kim, SY; Kim, YS; Lee, SH; Moon, SW; Park, MS; Song, MJ | 1 |
| Alberti, ML; Campins, F; Caro, FM; Enghelmayer, JI; Fernández, ME; Lancellotti, D; Papucci, T; Paulin, F; Sebastiani, JA | 1 |
| Akira, M; Arai, T; Hayashi, S; Inoue, Y; Kitaichi, M; Nakao, K; Okuma, T; Sasaki, Y; Sugimoto, C; Tachibana, K | 1 |
1 review(s) available for pirfenidone and Nausea
| Article | Year |
|---|---|
The effects and safety of pirfenidone in the treatment of idiopathic pulmonary fibrosis: a meta-analysis and systematic review.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Diarrhea; Exanthema; Humans; Idiopathic Pulmonary Fibrosis; Lung; Nausea; Progression-Free Survival; Pyridones; Treatment Outcome; Vital Capacity | 2021 |
3 other study(ies) available for pirfenidone and Nausea
| Article | Year |
|---|---|
Efficacy of low dose pirfenidone in idiopathic pulmonary fibrosis: real world experience from a tertiary university hospital.
Topics: Aged; Anorexia; Anti-Inflammatory Agents, Non-Steroidal; Disease Progression; Dyspepsia; Female; Hospitals, University; Humans; Idiopathic Pulmonary Fibrosis; Male; Middle Aged; Nausea; Pyridones; Retrospective Studies; Tertiary Care Centers; Treatment Outcome; Vital Capacity | 2020 |
Real-Life Experience with Pirfenidone in Idiopathic Pulmonary Fibrosis in Argentina. A Retrospective Multicenter Study.
Topics: Aged; Argentina; Asthenia; Clinical Trials, Phase III as Topic; Exanthema; Female; Humans; Idiopathic Pulmonary Fibrosis; Male; Nausea; Pyridones; Randomized Controlled Trials as Topic; Retrospective Studies; Treatment Outcome; Vital Capacity | 2019 |
Predictors of the clinical effects of pirfenidone on idiopathic pulmonary fibrosis.
Topics: Aged; Anorexia; Anti-Inflammatory Agents, Non-Steroidal; Female; Histamine H2 Antagonists; Humans; Idiopathic Pulmonary Fibrosis; Logistic Models; Male; Middle Aged; Nausea; Predictive Value of Tests; Proportional Hazards Models; Proton Pump Inhibitors; Pyridones; Retrospective Studies; Severity of Illness Index; Survival Rate; Time Factors; Treatment Outcome; Vital Capacity | 2014 |